Supercharge Your Innovation With Domain-Expert AI Agents!

Oral medicine for treating high blood pressure disease

A technology of hypertension and medicine, applied in the field of plant materials, can solve the problems of insignificant curative effect and slow onset of effect

Inactive Publication Date: 2021-03-16
王红卫
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] Currently, there are Jiangya pills, Zhenxin Jiangya Tablets, Apocynum Jiangya Capsules, Yangyin Jiangya Capsules, Compound Prunellae Jiangya Granules, Juming Jiangya Tablets, etc. The common problem of traditional Chinese medicine antihypertensive drugs is that the onset of effect is slow and the curative effect is not significant

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Oral medicine for treating high blood pressure disease
  • Oral medicine for treating high blood pressure disease
  • Oral medicine for treating high blood pressure disease

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0025] Taking the production of 1000 capsules of the present invention as an example, the used bulk drug and adjuvant and their mass proportions are:

[0026]

[0027] Its preparation method is carried out according to the preparation method of the capsule of the present invention. Each capsule weighs 0.3g, and each capsule contains 4g of raw material drug, and it is taken orally three times a day, 4 capsules each time.

[0028] Taking the production of 1000 tablets of the pharmaceutical tablet product of the present invention as an example, the used bulk drug and auxiliary materials and their proportioning ratio are:

[0029]

[0030] Its preparation method is carried out according to the preparation method of the tablet of the present invention. Each tablet weighs 0.3g, and each tablet contains 4g of raw material drug, and is taken orally three times a day, 4 tablets each time.

[0031] Taking the production of 1000 grams of the granule product of the present inventi...

Embodiment 2

[0040] Taking the production of 1000 capsules of the present invention as an example, the used bulk drug and adjuvant and their mass proportions are:

[0041]

[0042] Its preparation method is carried out according to the preparation method of the capsule of the present invention. Each capsule weighs 0.3g, and each capsule contains 4g of raw material drug, and it is taken orally three times a day, 4 capsules each time.

[0043] Taking the production of 1000 tablets of the pharmaceutical tablet product of the present invention as an example, the used bulk drug and adjuvant and its mass proportioning are:

[0044]

[0045] Its preparation method is carried out according to the preparation method of the tablet of the present invention. Each tablet weighs 0.3g, and each tablet contains 4g of raw material drug, and is taken orally three times a day, 4 tablets each time.

[0046] Taking the production of 1000 grams of the granule product of the present invention as an examp...

Embodiment 3

[0055] Taking the production of 1000 capsules of the present invention as an example, the used bulk drug and adjuvant and their mass proportions are:

[0056]

[0057] Its preparation method is carried out according to the preparation method of the capsule of the present invention. Each capsule weighs 0.3g, and each capsule contains 4g of raw material drug, and it is taken orally three times a day, 4 capsules each time.

[0058] Taking the production of 1000 tablets of the pharmaceutical tablet product of the present invention as an example, the used bulk drug and auxiliary materials and their proportioning ratio are:

[0059]

[0060]

[0061] Its preparation method is carried out according to the preparation method of the tablet of the present invention. Each tablet weighs 0.3g, and each tablet contains 4g of raw material drug, and is taken orally three times a day, 4 tablets each time.

[0062] Taking the production of 1000 grams of the granule product of the pre...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an oral medicine for treating the high blood pressure disease. The oral medicine is prepared from the following traditional Chinese medicines according to a conventional preparation method, wherein the traditional Chinese medicines include 6-10 parts by weight of cortex eucommiae, 16-22 parts by weight of radix codonopsis, 3-9 parts by weight of scutellariae radix, 3-9 parts by weight of rubiae radix and 8-12 parts by weight of herba leonuri.The oral medicine comprises capsules, tablets, granules and oral solutions. Through a medicine effect experiment, the average effective rate of the oral medicine disclosed by the invention is 94%, and a treatment effect is obvious. An experiment result indicates that the oral medicine disclosed by the invention has a function ofreducing blood pressure and can be used as a high blood pressure chronic disease medicine.

Description

technical field [0001] The invention belongs to the technical field of medical preparations containing raw materials or their reaction products with unknown structures, and specifically relates to materials derived from plants. Background technique [0002] Hypertension refers to a syndrome characterized by sustained elevation of systemic systolic or diastolic blood pressure as the main clinical manifestation, with or without multiple cardiovascular risk factors. In the absence of antihypertensive drugs, systolic blood pressure ≥ 140 mm Hg and / or diastolic blood pressure ≥ 90 mm Hg, and persists, usually referred to simply as "hypertension" [0003] Hypertension seriously endangers people's health and life. It is not only an independent disease, but also an important risk factor for cardiovascular and cerebrovascular diseases, leading to changes and damages in the structure and function of the heart, brain, kidney, blood vessels, and fundus. The mortality rate of cardiovas...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/74A61K9/08A61K9/20A61K9/48A61K9/16A61P9/12
CPCA61K9/0095A61K9/1652A61K9/2059A61K9/4866A61K36/344A61K36/46A61K36/533A61K36/539A61K36/74A61K2236/331A61K2236/39A61K2236/51A61P9/12A61K2300/00
Inventor 王红卫
Owner 王红卫
Features
  • R&D
  • Intellectual Property
  • Life Sciences
  • Materials
  • Tech Scout
Why Patsnap Eureka
  • Unparalleled Data Quality
  • Higher Quality Content
  • 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com